- Home
- MREO vs LFVN Comparison
MREO vs LFVN Comparison
Compare MREO & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MREO | LFVN |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 54.9M |
| IPO Year | 2017 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MREO | LFVN |
|---|---|---|
| Price | $0.33 | $4.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $1.50 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 1.4M | 75.1K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.48% |
| EPS Growth | 16.67 | ★ 226.09 |
| EPS | N/A | ★ 0.19 |
| Revenue | $500,000.00 | ★ $203,204,000.00 |
| Revenue This Year | $6,000.20 | N/A |
| Revenue Next Year | $34.71 | N/A |
| P/E Ratio | ★ N/A | $21.16 |
| Revenue Growth | N/A | ★ 1.86 |
| 52 Week Low | $0.20 | $3.90 |
| 52 Week High | $2.94 | $15.29 |
Technical Indicators
Market Signals| Indicator | MREO | LFVN |
|---|---|---|
| Relative Strength Index (RSI) | 41.57 | 35.17 |
| Support Level | $0.32 | $3.99 |
| Resistance Level | $0.42 | $5.37 |
| Average True Range (ATR) | 0.02 | 0.24 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 42.31 | 20.00 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.